BCV
EW icon

Banque Cantonale Vaudoise’s Edwards Lifesciences EW Stock Holding History

Banque Cantonale Vaudoise’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.99M Sell
62,297
-4,145
-6% -$342K 0.19% 111
2025
Q4 		$5.66M Sell
66,442
-39
-0.1% -$3.2K 0.2% 94
2025
Q3 		$5.17M Sell
66,481
-185
-0.3% -$14.5K 0.19% 96
2025
Q2 		$5.21M Buy
66,666
+24,899
+60% +$1.86M 0.21% 90
2025
Q1 		$3.03M Buy
+41,767
New +$2.99M 0.13% 153
2024
Q3 		$5.35M Buy
81,111
+25,886
+47% +$1.88M 0.22% 103
2024
Q2 		$5.1M Sell
55,225
-2,986
-5% -$264K 0.2% 90
2024
Q1 		$5.56M Sell
58,211
-1,724
-3% -$145K 0.22% 84
2023
Q4 		$4.57M Buy
59,935
+25,671
+75% +$1.79M 0.2% 93
2023
Q3 		$2.38M Buy
34,264
+3,939
+13% +$317K 0.12% 142
2023
Q2 		$2.86M Buy
30,325
+5,193
+21% +$451K 0.13% 132
2023
Q1 		$2.08M Sell
25,132
-3,909
-13% -$307K 0.1% 194
2022
Q4 		$2.17M Sell
29,041
-2,198
-7% -$169K 0.11% 175
2022
Q3 		$2.58M Sell
31,239
-13
-0% -$1.25K 0.15% 136
2022
Q2 		$2.97M Sell
31,252
-1,136
-4% -$118K 0.15% 126
2022
Q1 		$3.81M Sell
32,388
-955
-3% -$107K 0.16% 119
2021
Q4 		$4.32M Sell
33,343
-5,787
-15% -$675K 0.17% 120
2021
Q3 		$4.43M Buy
39,130
+2,621
+7% +$299K 0.19% 103
2021
Q2 		$3.78M Sell
36,509
-1,627
-4% -$153K 0.17% 126
2021
Q1 		$3.19M Sell
38,136
-3,117
-8% -$264K 0.16% 130
2020
Q4 		$3.76M Buy
41,253
+863
+2% +$71.6K 0.21% 99
2020
Q3 		$3.22M Sell
40,390
-111
-0.3% -$8.66K 0.21% 103
2020
Q2 		$2.8M Buy
40,501
+8,206
+25% +$583K 0.2% 106
2020
Q1 		$2.03M Sell
32,295
-10,941
-25% -$789K 0.17% 129
2019
Q4 		$3.36M Buy
+43,236
New +$3.38M 0.23% 89

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Banque Cantonale Vaudoise's EW Position: Q1 2026 in Review

Banque Cantonale Vaudoise reduced its Edwards Lifesciences (EW) stake by 6.2% in Q1 2026, selling an estimated $342K and leaving 62,297 shares worth $4.99M. The position accounts for 0.19% of the portfolio, ranked #111.

Banque Cantonale Vaudoise first reported a position in EW in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.66M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Banque Cantonale Vaudoise held 62,297 shares of Edwards Lifesciences worth $4.99M as of Q1 2026.
  • Banque Cantonale Vaudoise sold 4,145 Edwards Lifesciences shares in Q1 2026, an estimated $342K.
  • Edwards Lifesciences made up 0.19% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #111 holding.
  • Banque Cantonale Vaudoise first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's Edwards Lifesciences position peaked at $5.66M in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.